The effect of a walking bike on exercise capacity in patients with COPD and chronic heart failure

The effect of a walking bike on exercise capacity in patients with COPD and chronic heart failure - Walking bike in COPD and chronic heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35160

Enrollment

Registered

2011-12-21

Start date

2012-01-15

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure COPD

Interventions

All patients will perform 6MWT*s and 400m tests using a walking bike or rollator in random order.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients: 45-80 yr, familiar with 6MWT;group 1COPD: pulmonologist's diagnosis of COPD Gold II or III;group 2 chronic heart failure: cardiologist's diagnosis of chronic heart failure NYHA 3 or 4

Exclusion criteria

Exclusion criteria: All patients: Disability limiting the ability to walk Need for oxygen supplementation during exercise Being used to walking with walking aid;group 1 COPD: exacerbation COPD last 6 wks history of congestive heart failure;group 2 chronic heart failure: cardiac deterioration leading to hospital admission last 6 weeks COPD

Design outcomes

Primary

Measure	Time frame
The change (in meters) in 6 minute walking distance using a rollator versus a walking bike	—

Secondary

Measure	Time frame
The changes in dyspnea (Borg), leg fatigue (Borg), heart rate, breathing frequency, pulse, oxygen saturation, and inspiratory capacity (IC) during the walking tests. Differences in levels of shame (Borg score) and satisfaction (adjusted QUEST score) with rollator vs walking bike. Differences between patients with COPD and chronic heart failure with respect to responses on walking with rollator versus walking bike. Baseline characteristics will be used to identify potential predictors of response.	—

Measure

Time frame

The changes in dyspnea (Borg), leg fatigue (Borg), heart rate, breathing frequency, pulse, oxygen saturation, and inspiratory capacity (IC) during the walking tests. Differences in levels of shame (Borg score) and satisfaction (adjusted QUEST score) with rollator vs walking bike. Differences between patients with COPD and chronic heart failure with respect to responses on walking with rollator versus walking bike. Baseline characteristics will be used to identify potential predictors of response.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)